The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology)

 
   Single User - $4,500
   Site License (one location, 10 users) - $6,750
   Corporate License - $9,000



Loading...
Published Apr 10, 2018 | 272 Pages | Pub ID: KLI15652532

The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology)

Clinical microbiology laboratories perform tests to detect, isolate, identify and characterize microorganisms that cause infectious diseases, and also perform antibiotic susceptibility tests. This is a diverse market. Traditional microbiology, including culture, microscopy, use of stains plus fluorogenic and chromogenic substrates, and other technologies has been used for several decades in microbiology laboratories. Microbiology tests may be performed using traditional microbiology techniques, or by using newer technologies including immunoassays, molecular microbiology (PCR or other nucleic acid amplification methods), or mass spectrometry. The Worldwide Microbiology Market provides analysis of the current global market, looking at the current and future market by segment, by pathogen/disease, by geographic region, and by major company market shares, including the following data points:
  • Worldwide Microbiology Market, by Segment, 2017-2022 (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology, Total Microbiology Market)
  • Major Pathogens/Disease Indications in Microbiology/Infectious Disease Market, 2017 (%) (Healthcare-Acquired Infections / Antimicrobial Resistance, STDs / Women's Health, Hepatitis, HIV, Respiratory Tract Infections, Others)
  • Worldwide Microbiology Market, by Geographic Region, 2017-2022 (North America, Western Europe, Japan, China, India, Latin America, Rest of the World, Total Microbiology Market)
  • Worldwide Traditional Microbiology Market, by Segment, 2017-2022 (Automated ID/AST Systems, Manual ID/AST Systems, Blood Culture, Chromogenic Media, Rapid Microbiology, Total Traditional Microbiology Market)
  • Worldwide Traditional Microbiology Market, by Geographic Region, 2017-2022 (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), Rest of the World, Total Traditional Microbiology Market)
  • Market Shares of Selected Companies in the Traditional Microbiology Market (%)
  • Worldwide Microbiology/Infectious Disease Immunoassay Market, by Segment, 2017-2022 (Laboratory-Based Immunoassays, Rapid/Point-of-Care Immunoassays, Total Microbiology/Infectious Disease Immunoassay Market)
  • Worldwide Microbiology/Infectious Disease Immunoassay Market, by Geographic Region, 2017-2022 (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), Rest of the World, Total Microbiology/Infectious Disease Immunoassay Market)
  • Worldwide Clinical Laboratory-Based Microbiology/Infectious Disease Immunoassay Market, by Pathogen/Disease Indication, 2017 (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others [includes immunoassays for EBV, Chagas, Dengue, Malaria, etc.], Total)
  • Worldwide Rapid Microbiology/Infectious Disease Immunoassay Market, by Pathogen/Disease Indication, 2017 (Influenza, HIV, Malaria, Hepatitis, STDs [includes Chlamydia and syphilis], C. difficile, E. coli, Strep A, H. pylori, Home Test / OTC, Others, Total)
  • Worldwide Molecular Microbiology Market, by Pathogen/Disease Indication, 2017-2022 (Hepatitis, HIV, Healthcare Acquired Infections and Sepsis, Respiratory Pathogens, Sexually Transmitted Diseases and Women’s Health, Tuberculosis, Other, Total Worldwide Molecular Microbiology Market)
  • Worldwide Molecular Microbiology Market, by Geographic Region, 2017-2022 (North America, Western Europe, Japan, China, India, Latin America, Rest of the World, Total - World Molecular Microbiology Market)
  • Major Company Market Shares in Molecular Microbiology Diagnostic Testing (%)
  • Worldwide Microbiology Mass Spectrometry Market, 2017-2022
A wide range of technologies are used today to detect and characterize pathogens, or to detect the effect an infectious disease pathogen has on a patient’s body. Selected technologies used for infectious disease diagnostics are discussed in the report, including:
  • Traditional Microbiology: Identification and antibiotic susceptibility/sensitivity testing (ID/AST), which includes the following product categories: microbial ID/AST systems, and panels and reagents for ID/AST systems; chromogenic media; rapid tests done on colonies selected from culture media; and blood culture bottles and systems
  • Mass Spectrometry: The development of MALDI-TOF mass spectrometers has made it possible to apply mass spectrometry to infectious disease diagnostics applications, and mass spectrometers are now being used in microbiology laboratories for rapid identification of pathogens following cell culture
  • Immunoassays: Those discussed include traditional rapid assays (flow through assays and immunolochromatographic tests) and enzyme immunoassays
  • Polymerase Chain Reaction and Other Nucleic Acid Amplification Technologies: Assays based on PCR and certain other nucleic acid amplification technologies are widely used in clinical laboratories, and are penetrating near patient and point-of-care settings
The Worldwide Microbiology Market also looks at advances in molecular microbiology. Until recently, sequencing applications in microbiology have been limited. This is starting to change. At this time, next generation sequencing based tests are mostly laboratory developed tests for oncology or genetic testing. However, companies are starting to apply next generation sequencing to infectious disease diagnostics. The report outlines selected companies applying DNA/RNA sequencing to microbiology.

The report contains profiles of a wide range of companies that are active in the clinical microbiology market, which includes companies that in the traditional microbiology market, immunoassay market, molecular microbiology market, and also mass spectrometry systems for the microbiology laboratory. The companies profiled are the following:
  • 3i Diagnostics, Inc. (3iDx)
  • Abbott
  • Accelerate Diagnostics, Inc.
  • Atlas Genetics Ltd.
  • AutoGenomics, Inc.
  • Beckman Coulter, Inc. (A Danaher Corporation Company)
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • BioFire Diagnostics, LLC. (Acquired by bioMérieux)
  • bioMérieux SA
  • Bruker Corporation
  • Cepheid (A Danaher Company)
  • COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
  • Curetis
  • DiaSorin S.p.A.
  • ELITech Group
  • GenePOC Inc.
  • GenMark Diagnostics, Inc.
  • Hologic, Inc.
  • Janssen Diagnostics (Janssen Pharmaceutical Companies of Johnson & Johnson)
  • Luminex Corporation
  • Mast Group
  • Q-linea AB
  • QIAGEN N.V.
  • QuanDx Inc.
  • QuantuMDx Group
  • Quidel, Inc.
  • Qvella Corporation
  • Rheonix, Inc.
  • Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.
  • Xagenic Inc.
The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts.
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.